The framework has shifted from markdown to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 12.3% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is holding around 0% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 4%. Our forward projection puts the odds of a 10% gain over the next month near 15%. The street (9 analysts) rates it none, with a mean price target of $252.
Reinsurance Group Of America Inc RGA
Outside both standards
An entry written while the outcome is still unknown. It will be scored by what the market does next, and it will never be edited to look cleverer than it was.
In plain words · Reinsurance Group of America, Incorporated provides life and health, and asset-intensive reinsurance in the United States, Latin America, Canada, Europe, the Middle East, Africa, Asia, and Australia.
read at $236.31
Reinsurance Group Of America Inc holds its Markup at $236.31.
- PHPhase · the trend structure carries the Markup label
- INInsiders · no filings inside 60 days, left as found
- POPositioning · no disclosures inside 60 days, left as found
- OPOptions · no verdict drawn today, left as found
- SCScreen · does not pass the values gate
- edge confirmed
- edge broken
- edge forming
Each arm is one independent read. Conviction is not a single call, it is how many edges converge.
The investor read · the season, not the day
| Phase | Markup |
| Quantitative state | The statistical read favours the sellers, held for 61 days |
| Price | $236.31 |
| Valuation | 12.85 trailing · 8.08 forward price to earnings |
| Values screen | FAIL · score 30.0 |
| Beta | 0.46 |
The opportunity · what the numbers say it is worth
Price history & projections · where it has been, where the models see it going
The valuation journey · where the price sits against fair value and the Street
Green marks levels above today's price, red below; the shaded band is the gap between the price and our fair value.
Reading the gap · Both our model and the analysts see meaningful upside from here.
| Revenue growth | 23.50% |
| Profit margin | 4.92% |
| Debt to equity | 45.61 |
| Analyst consensus | Buy · 9 covering |
Fair value and rating are our own model estimates; target range reflects third-party analyst estimates. Analysis, not advice.
The values screen, explained · five checks, plain English
This company is excluded by both standards. There are two widely recognised ways to check whether a company is suitable for a Muslim investor. It fails on both:
Used by most halal investing apps ✗ DOES NOT PASS
The one Titan applies ✗ DOES NOT PASS
Why it fails. The problem is its excluded industry: insurance - reinsurance. Because both standards agree on this, it is a clear exclusion, not a borderline case.
What these two standards are, and how they differ →
- Business activity Excluded industry: Insurance - Reinsurance Fail
- Debt load Interest-bearing debt is of its assets, above the one-third ceiling the screen allows. Fail
- Interest-bearing cash Interest-bearing cash and securities are of assets, above the one-third limit. Fail
- Receivables Money owed to the company is of assets, above the 49% limit. Fail
- Revenue purity of revenue comes from non-compliant sources, over the 5% line. Fail
Every security is read against two recognised standards: our stricter asset-based screen (ratios measured against total assets) and the more widely used market-value standard (measured against market capitalisation). Where they agree we say so plainly; where they part ways — almost always on the debt check — we show both readings and mark it, because that disagreement is the finding, not a fault. We report the score; you and your scholar make the call.
The business, in plain words · what the numbers mean
Reinsurance pays out when the worst hits
Reinsurance sits behind every big insurance payout, quietly taking the risk off primary carriers when claims spike. Reinsurance Group of America handles life and health covers across dozens of markets and shows 24% revenue growth alongside a forward P/E of 8.3x. Yet the numbers never reach our desk.
We pass outright. The business fails our ethical screen on excluded industry grounds, full stop. No valuation discount or analyst consensus changes that line.
The narrow moat, 10% ROE and 5% profit margin already flag limited durability in a capital-heavy sector. Currency swings, regulatory shifts and long-tail claims add further volatility that the low multiple simply prices in rather than resolves. Analysis, not advice.
| Forward P/E | 8.1x cheap for a company growing this fast |
| Trailing P/E | 12.8x reasonably valued |
| Revenue growth | 23.5% strong top-line growth |
| Profit margin | 4.9% barely profitable |
| Return on equity | 9.9% a modest return on shareholder capital |
| Debt to equity | 0.46 minimal debt — a conservative balance sheet |
| Current ratio | 1.12 adequate liquidity, worth monitoring |
| Beta | 0.46 barely tracks the market's swings |
| Market cap | $15.5B |
| Employees | 4,300 |
The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.
Plain-English interpretation of our own screen data. Analysis, not advice.
Related securities · others in RGA's space worth a look
Screened names in the same industry · explore each on its own page.
The trader read · the latest dated commentary
The dated journal · newest first, never edited
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is holding around 0% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 4%. Our forward projection puts the odds of a 10% gain over the next month near 15%. The street (9 analysts) rates it none, with a mean price target of $252.
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns.
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
The political ledger · congressional disclosures
| Date | Politician | Party | Type | Amount |
|---|---|---|---|---|
| 6 May2026 | Kevin Hern | Republican | sell | 1M–5M |
| 30 Jun2026 | Gil Cisneros | Democrat | buy | 15K–50K |
| 27 Mar2026 | Alan Armstrong | Republican | buy | 1K–15K |
| 21 May2026 | Ro Khanna | Democrat | buy | 100K–250K |
| 2026-05-08 | Bill Keating | Democrat | Purchase | 1K–15K |
What holding actually paid · price plus dividends
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $208.56 | -0.8% | $0.93 | $997 | -0.3% |
| 2 months | $204.16 | +1.4% | $0.93 | $1,018 | +1.8% |
| 3 months | $204.11 | +1.4% | $0.93 | $1,018 | +1.8% |
| 6 months | $201.20 | +2.8% | $1.86 | $1,038 | +3.8% |
| 1 year | $198.22 | +4.4% | $3.72 | $1,063 | +6.3% |
| 2 years | $197.37 | +4.8% | $7.28 | $1,085 | +8.5% |
| 3 years | $136.43 | +51.7% | $10.68 | $1,595 | +59.5% |
| 5 years | $111.91 | +84.9% | $16.80 | $1,999 | +99.9% |
Historical returns from market close data. Past performance does not guarantee future results.